| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 1,069 | 594 | 732 | | | Gross Profit | (1,069) | (594) | (732) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 912 | 1,293 | 840 | | Non Recurring |
-
|
-
|
-
| | Others | 300 | 174 | 225 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,282) | (2,061) | (1,797) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6 | (8,712) | (13,683) | | Earnings Before Interest And Taxes | (2,276) | (10,773) | (15,480) | | Interest Expense | 3,041 | 5,267 | 2,853 | | Income Before Tax | (5,316) | (16,040) | (18,333) | | Income Tax Expense |
-
| 0 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,316) | (16,040) | (18,333) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,316) | (16,040) | (18,333) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,316) | ($16,040) | ($18,333) |
|
0.75% Nasdaq 
Income Statement
